Literature DB >> 12784877

Current surgical management of glioblastoma.

Stephen J Hentschel1, Frederick F Lang.   

Abstract

Surgical resection is a critical aspect of the management of a patient with a glioblastoma (GBM). An intimate knowledge of the anatomy of a GBM, as well as familiarity with particular surgical techniques and adjunctive technologies is required for safe surgical resection. The goals of resection include diagnosis, relief of mass effect, and cytoreduction. A recent study showed that resection of 98% or more of the tumor mass can result in a statistically significant survival advantage. Even in functionally critical areas, "gross total" resections are possible if proper techniques are employed. It is recommended that a "gross total" resection of the enhancing portion of a GBM be performed whenever possible. With this philosophy, the mortality rate is 3% and the rate of major neurologic morbidity is less than 10%.

Entities:  

Mesh:

Year:  2003        PMID: 12784877     DOI: 10.1097/00130404-200303000-00007

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  15 in total

1.  GBM skin metastasis: a case report and review of the literature.

Authors:  Gary D Lewis; Andreana L Rivera; Ivo W Tremont-Lukats; Leomar Y Ballester-Fuentes; Yi Jonathan Zhang; Bin S Teh
Journal:  CNS Oncol       Date:  2017-07-18

Review 2.  Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy.

Authors:  Mamta Wankhede; Alexandros Bouras; Milota Kaluzova; Costas G Hadjipanayis
Journal:  Expert Rev Clin Pharmacol       Date:  2012-03       Impact factor: 5.045

3.  Glioblastoma multiforme in the elderly: a therapeutic challenge.

Authors:  A Mangiola; G Maira; P De Bonis; M Porso; B Pettorini; G Sabatino; C Anile
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

Review 4.  Prospective clinical trials of brain tumor therapy: the critical role of neurosurgeons.

Authors:  Frederick F Lang; Anthony Asher
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

5.  Evaluation of preoperative high magnetic field motor functional MRI (3 Tesla) in glioma patients by navigated electrocortical stimulation and postoperative outcome.

Authors:  K Roessler; M Donat; R Lanzenberger; K Novak; A Geissler; A Gartus; A R Tahamtan; D Milakara; T Czech; M Barth; E Knosp; R Beisteiner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

6.  Radio-Pathomic Maps of Cell Density Identify Brain Tumor Invasion beyond Traditional MRI-Defined Margins.

Authors:  S A Bobholz; A K Lowman; M Brehler; F Kyereme; S R Duenweg; J Sherman; S D McGarry; E J Cochran; J Connelly; W M Mueller; M Agarwal; A Banerjee; P S LaViolette
Journal:  AJNR Am J Neuroradiol       Date:  2022-04-14       Impact factor: 3.825

7.  Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme.

Authors:  Nicholas Butowski; Kathleen R Lamborn; Mitchel S Berger; Michael D Prados; Susan M Chang
Journal:  J Neurooncol       Date:  2007-04-25       Impact factor: 4.130

8.  Apoptosis-inducing effect of myxoma virus on human neuroglioma cell lines.

Authors:  Qiu-Sheng Zhang; Meng Zhang; Xian-Jian Huang; Xiao-Jia Liu; Wei-Ping Li
Journal:  Exp Ther Med       Date:  2017-05-22       Impact factor: 2.447

Review 9.  Diffuse glioma growth: a guerilla war.

Authors:  An Claes; Albert J Idema; Pieter Wesseling
Journal:  Acta Neuropathol       Date:  2007-09-06       Impact factor: 17.088

10.  Glioblastoma patients in Slovenia from 1997 to 2008.

Authors:  Uros Smrdel; Viljem Kovac; Mara Popovic; Matjaz Zwitter
Journal:  Radiol Oncol       Date:  2014-01-22       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.